YS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call Transcript April 19, 2024 YS Biopharma Co., Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by and welcome to YS Biopharma’s Earnings Call […]
YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) shares were down 3.4% during mid-day trading on Friday . The company traded as low as $0.39 and last traded at $0.40. Approximately 99,903 shares were traded during trading, a decline of 41% from the average daily volume of 168,291 shares. The stock had previously closed […]
Noble Financial assumed coverage on shares of YS Biopharma (NASDAQ:YS – Free Report) in a research report released on Monday morning, Benzinga reports. The brokerage issued an outperform rating and a $5.25 price target on the stock. YS Biopharma Stock Down 1.4 % NASDAQ YS opened at $0.65 on Monday. The company has a current […]
YS Biopharma Co., Ltd. (NASDAQ:YS – Get Free Report) saw a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 98,300 shares, a drop of 86.1% from the August 31st total of 706,300 shares. Based on an average trading volume of 922,700 shares, the days-to-cover […]
By Chris Wack YS Biopharma shares were up 9% to $1 after the company said Friday that the U.S. Patent and Trademark Office has issued it a patent covering.